Ruiwen Zhang to Prognosis
This is a "connection" page, showing publications Ruiwen Zhang has written about Prognosis.
Connection Strength
0.324
-
Targeting MDM2 for novel molecular therapy: Beyond oncology. Med Res Rev. 2020 05; 40(3):856-880.
Score: 0.164
-
MDM2-NFAT1 dual inhibitor, MA242: Effective against hepatocellular carcinoma, independent of p53. Cancer Lett. 2019 09 10; 459:156-167.
Score: 0.160